DCT

2:24-cv-00264

Regeneron Pharma Inc v. Amgen Inc

General
Filed
01/10/24
Cause of ActionPatent Infringement
SectorBiotech
StatusClosed
Patent Owner
Operating Company
Nature of Suit830 Patent
Judge
Period
PO Win Rate
01/23/24 - 05/23/24
55%